Brief: Quanterix Launches Lucentad Biomarker Blood Test To Aid Physician Diagnosis Of Alzheimer’S Disease
06/07/2023 23:11
July 6 (Reuters) - Quanterix Corp QTRX.O :
* QUANTERIX LAUNCHES LUCENTAD BIOMARKER BLOOD TEST TO AID
PHYSICIAN DIAGNOSIS OF ALZHEIMER’S DISEASE IN PATIENTS
Source text for Eikon: ID:nBw2h9WHra
Further company coverage: QTRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview